Business, energy, technology, markets and global industry news from Business News Today

Roche Diagnostics

PharmaDeviceNews Roche Diagnostics
FDA clears Roche cobas BV/CV PCR assay for symptomatic vaginitis diagnosis
Medical Devices & Diagnostics

Roche’s new vaginitis PCR test is FDA-cleared, but the real commercial test starts inside laboratories

Roche’s cobas BV/CV assay gains FDA clearance for combined BV and Candida testing, setting up a 2026 U.S. laboratory launch.

Read More
Representative image: A pathology specialist reviews PTEN biomarker staining as NeoGenomics launches an FDA-approved companion diagnostic to identify prostate cancer patients who may be eligible for AstraZeneca’s Truqap.
Medical Devices & Diagnostics

How the NeoGenomics PTEN IHC test supports targeted prostate cancer treatment

NeoGenomics launches an FDA-approved PTEN IHC companion diagnostic to identify prostate cancer patients eligible for AstraZeneca’s Truqap.

Read More
Representative image: Targeted prostate cancer treatment enters focus as AstraZeneca’s Truqap approval highlights PTEN-deficient metastatic disease, biomarker testing, and the future of precision oncology.
Medical Devices & Diagnostics

Why AstraZeneca’s Truqap win could force a new testing era in prostate cancer

Find out how AstraZeneca’s Truqap approval could reshape PTEN-deficient prostate cancer treatment and biomarker testing.

Read More
Representative image: Roche’s $1.05bn PathAI acquisition highlights how AI-powered digital pathology could accelerate tissue analysis, companion diagnostics, and precision oncology workflows across modern diagnostics laboratories.
Medical Devices & Diagnostics

What Roche’s $1.05bn PathAI move reveals about the future of pathology labs

Roche wants AI pathology at scale. PathAI gives it the tissue-analysis layer needed to tighten diagnostics, trials, and precision oncology.

Read More